Publication Type: Original Research

June, 2014

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population

JAMA 2014:311:2305-2314

SIGMA Type 2 Diabetes Consortium, Estrada K, (…), González-Villalpando C, Orozco L, Haiman CA, Tusié-Luna T, Aguilar-Salinas CA, Altshuler D, Njølstad PR, Florez JC†, MacArthur DG.

IMPORTANCE: Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES: To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS: Whole-exome sequencing was performed …

Read More…

June, 2014

Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity

Diabetes 2014;63:2158-2171

Dimas AS*, Lagou V*, Barker A*, Knowles JW*, (…), Watanabe RM†, Florez JC†, Ingelsson E†, McCarthy MI†, Prokopenko I† on behalf of the MAGIC investigators

Patients with established type 2 diabetes display both ?-cell dysfunction and insulin resistance. To define fundamental processes leading to the diabetic state, we examined the relationship between type 2 diabetes risk variants at 37 established susceptibility loci, and indices of proinsulin processing, insulin secretion, and insulin sensitivity. We included data from up to 58,614 nondiabetic …

Read More…

May, 2014

The influence of rare genetic variation in SLC30A8 on diabetes incidence and beta-cell function

J Clin Endocrinol Metab 2014;99:E926-E930

Billings LK, Jablonski KA, Ackerman RJ, Taylor A, Fanelli RR, McAteer JB, Guiducci C, Delahanty LM, Dabelea D, Kahn SE, Franks PW, Hanson RL, Maruthur NM, Shuldiner A, Mayer-Davis EJ, Knowler WC, Florez JC for the Diabetes Prevention Program Research Group

CONTEXT/OBJECTIVE: The variant rs13266634 in SLC30A8, encoding a ?-cell-specific zinc transporter, is associated with type 2 diabetes. We aimed to identify other variants in SLC30A8 that increase diabetes risk and impair ?-cell function, and test whether zinc intake modifies this risk. DESIGN/OUTCOME: We sequenced exons in SLC30A8 in 380 Diabetes Prevention Program (DPP) participants and …

Read More…

February, 2014

Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico

Nature 2014;506:97-101

The SIGMA Type 2 Diabetes Consortium, Williams AL, Jacobs SB, Moreno-Macías H, Huerta-Chagoya A, Churchhouse C, Márquez-Luna C, García-Ortíz H, Gómez-Vázquez MJ, Burtt NP, Aguilar-Salinas CA, González-Villalpando C, Florez JC, Orozco L, Haiman CA, Tusié-Luna T, Altshuler D.

Performing genetic studies in multiple human populations can identify disease risk alleles that are common in one population but rare in others, with the potential to illuminate pathophysiology, health disparities, and the population genetic origins of disease alleles. Here we analysed 9.2 million single nucleotide polymorphisms (SNPs) in each of 8,214 Mexicans and other Latin …

Read More…

August, 2013

Chromosome 2q31.1 is associated with ESRD in women with type 1 diabetes

J Am Soc Nephrol 2013;24:1537-1543

Sandholm N, McKnight AJ, Salem RM, Brennan EP, Forsblom C, Harjutsalo V, Mäkinen V-P, McKay GJ, Sadlier DM, Williams WW, Martin F, Panduru NM, Tarnow L, Tuomilehto J, Tryggvason K, Zerbini G, Comeau ME, Langefeld CD for the FIND Consortium, Godson C, Hirschhorn JN, Maxwell AP, Florez JC, Groop P-H for the FinnDiane Study Group and the GENIE Consortium

Sex and genetic variation influence the risk of developing diabetic nephropathy and ESRD in patients with type 1 diabetes. We performed a genome-wide association study in a cohort of 3652 patients from the Finnish Diabetic Nephropathy (FinnDiane) Study with type 1 diabetes to determine whether sex-specific genetic risk factors for ESRD exist. A common variant, …

Read More…

September, 2012

New susceptibility loci associated with kidney disease in type 1 diabetes

PLoS Genet 2012;8:e1002921

Sandholm N*, Salem RM*, McKnight AJ*, Brennan EP*, (…), Hirschhorn JN†, Godson C†, Florez JC†, Groop PH† and Maxwell AP†

Diabetic kidney disease, or diabetic nephropathy (DN), is a major complication of diabetes and the leading cause of end-stage renal disease (ESRD) that requires dialysis treatment or kidney transplantation. In addition to the decrease in the quality of life, DN accounts for a large proportion of the excess mortality associated with type 1 diabetes (T1D). …

Read More…

August, 2012

Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy

Diabetes 2012;61:2187-2194

Williams WW*, Salem RM*, McKnight AJ*, Sandholm N*, (…), Godson C, Hirschhorn JN, Maxwell AP, Groop P-H, Florez JC for the GENIE Consortium

We formed the GEnetics of Nephropathy-an International Effort (GENIE) consortium to examine previously reported genetic associations with diabetic nephropathy (DN) in type 1 diabetes. GENIE consists of 6,366 similarly ascertained participants of European ancestry with type 1 diabetes, with and without DN, from the All Ireland-Warren 3-Genetics of Kidneys in Diabetes U.K. and Republic of …

Read More…

August, 2012

Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism

Diabetologia 2012;55:331-339

Walford GA, Green T, Neale B, Isakova T, Rotter JI, Grant SFA, Fox CS, Pankow JS, Wilson JG, Meigs JB, Siscovick DS, Bowden DW, Daly MJ, Florez JC

AIMS/HYPOTHESIS: Common genetic variants have been associated with type 2 diabetes. We hypothesised that a subset of these variants may have different effects on the transition from normal fasting glucose (NFG) to impaired fasting glucose (IFG) than on that from IFG to diabetes. METHODS: We identified 16 type 2 diabetes risk variants from the Illumina …

Read More…

February, 2012

The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program

Diabetes Care 2012;35:1864-1867

Florez JC, Jablonski KA, Taylor A, Mather K, Horton E, White NH, Barrett-Connor E, Knowler WC, Shuldiner AR, Pollin TI for the Diabetes Prevention Program Research Group

OBJECTIVE: The C allele at the rs11212617 polymorphism in the ataxia-telangiectasia-mutated (ATM) gene has been associated with greater clinical response to metformin in people with type 2 diabetes. We tested whether this variant modified the effect of metformin in the Diabetes Prevention Program (DPP), in which metformin reduced diabetes incidence by 31% in volunteers with …

Read More…

October, 2011

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

Diabetes 2011;60:2624-2634

Strawbridge RJ*, Dupuis J*, Prokopenko I*, Barker A*, Ahlqvist E*, (…), Langenberg C†, Hamsten A†, Florez JC†

OBJECTIVE: Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired ?-cell function, raised glucose levels, insulin resistance, and type 2 diabetes (T2D). Studies of the insulin processing pathway could provide new insights about T2D pathophysiology. RESEARCH DESIGN AND METHODS: We have conducted a meta-analysis of genome-wide association …

Read More…